Pharma feed

GlaxoSmithKline PLC
Informa· 17 Sep 2019

GSK Proposal For Novel Delivery NRT Leaves FDA Doubting 'Real World' Efficacy

All fields are required. Please make sure all fields are completed.

  • GlaxoSmithKline PLC
  • Informa PLC
  • Regulatory and Legal
  • Company Websites
Novo Nordisk AS
Novo Nordisk· 17 Sep 2019

Medtronic and Novo Nordisk enter agreement to provide integrated digital solutions for people with diabetes

Medtronic and Novo Nordisk enter agreement to provide integrated digital solutions for people with diabetes The new collaboration aims to develop solutions enabling dosing data from Novo Nordisk smart insulin pens to be shared with

  • Novo Nordisk AS
  • Medtronic
  • Partnerships and Alliances
  • Company Websites
N
GlaxoSmithKline PLC
Endpoints News· 17 Sep 2019

#UKBIO19: Join GSK’s Hal Barron and a group of top biotech execs for our 2nd annual biotech summit in London

John Car­roll Over the past 10 years I’ve made a point of get­ting to know the Gold­en Tri­an­gle and the spe­cial role the UK bio­phar­ma in­dus­try plays there in drug de­vel­op­ment. The con­cen­tra­tion of world class re­search in­sti­tutes, some of the most ac­com­plished sci­en­tists I’ve ever seen at work and a ris­ing tide of glob­al in­vest­ment cash leaves an im­pres­sion that there’s much, much more to come as biotech hubs are birthed and nur­tured.

  • GlaxoSmithKline PLC
  • Events
  • News Articles
  • News and Other Websites
Novo Nordisk AS
Informa· 17 Sep 2019

Medtronic And Novo Nordisk To Collaborate On Diabetes Devices

All fields are required. Please make sure all fields are completed.

  • Novo Nordisk AS
  • Medtronic
  • Informa PLC
  • Partnerships and Alliances
  • Company Websites
N
Sanofi
MDDI Online· 17 Sep 2019

Abbott’s FreeStyle Libre Catches Sanofi’s Eye in New Collaboration

Two powerhouses in pharma and medtech are working together to help people with diabetes better manage their condition. Abbott Laboratories and Sanofi will collaborate to integrate glucose sensing and insulin delivery technologies. The two companies will take an innovative approach to connected care by developing tools that combine the Abbott Park, Il-based company’s FreeStyle Libre technology with Paris-based Sanofi′s insulin dosing information.

  • Sanofi
  • Partnerships and Alliances
  • News Articles
  • News and Other Websites
N
Merck & Co., Inc.
Menafn· 17 Sep 2019

Merck Foundation provides their first 'Health Media Training' in partnership with the First Lady of Zimbabwe

(MENAFN - African Press Organization) Merck Foundation (Merck-Foundation.com) , the philanthropic arm of Merck KGaA Germany organized their first 'Merck Foundation Health Media Training” on 16th September 2019 in Harare, Zimbabwe in partnership with H.E. AUXILLIA MNANGAGWA , The First Lady of Zimbabwe and Ambassador of Merck More Than a Mother together with Ministries of Health and Information to break the stigma around infertility in Zimbabwe and rest of Africa.

  • Merck & Co., Inc.
  • Partnerships and Alliances
  • News Articles
  • News and Other Websites
  • Takeda Pharmaceutical Co Ltd
  • New Offerings
  • Social Updates
  • Twitter
N
Sanofi
Chemdiv· 17 Sep 2019

Sanofi to pay Lexicon $260 million for terminated partnership

Sanofi to pay Lexicon $260 million for terminated partnership (Reuters) – Lexicon Pharmaceuticals Inc said on Tuesday France’s Sanofi SA will pay the drugmaker $260 million for the termination of their partnership to develop diabetes drug Zynquista.

  • Lexicon
  • Sanofi
  • Partnerships and Alliances
  • News Articles
  • News and Other Websites
  • Lawrence M Koplin do
  • Allergan Inc
  • Partnerships and Alliances
  • Social Updates
  • Twitter
  • Sanofi
  • Abbott Molecular
  • Partnerships and Alliances
  • Social Updates
  • Twitter
N
Celgene Corp
BioSpace· 16 Sep 2019

Celgene's Acute Myeloid Leukemia Drug Likely to Hit Regulators in Early 2020

Celgene announced topline data from its Phase III QUAZAR AML-001 trial. The study evaluated CC-486, the company’s oral azacytidine, as maintenance treatment in newly-diagnosed acute myeloid leukemia (AML) patients who achieved first complete response (CR) or complete response with incomplete blood count recovery (CRi) with induction chemotherapy.

  • Celgene Corp
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
Twitter· 16 Sep 2019

#ICYMI: @Telegraph profiled #RADIAN, our new partnership with @ejaf to address #HIV infections and #AIDS-related deaths in Eastern Europe and Central Asia. Read more: https://t.co/MZyGkfJwDZ.

Stigma is holding back fight against Aids in Eastern Europe, warns David Furnish
David Furnish, Aids campaigner and husband of Sir Elton John, has condemned the homophobia and stigma that is hampering the control of HIV in Eastern Europe and Central Asia. Mr...
  • Gilead Sciences, Inc.
  • Partnerships and Alliances
  • Social Updates
  • Twitter
Twitter· 16 Sep 2019

“I’m honored to be @cscmp’s 2019 Distinguished Service Award recipient.” — Kathy Wengel, CSCO, #JNJ, on receiving the highest recognition in #supplychain.

Innovation & Imagination: 5 Questions for Johnson & Johnson's Chief Global Supply Chain Officer
E ver met someone whose job description includes overseeing some 50,000 people, close to 100 manufacturing facilities, hundreds more contract manufacturers and more than 300 dis...
  • Johnson & Johnson
  • Awards and Recognitions
  • Social Updates
  • Twitter
  • Coursera
  • Novartis AG
  • Partnerships and Alliances
  • Social Updates
  • Twitter
N
AstraZeneca PLC
Obroncology· 16 Sep 2019

AstraZeneca Redefines Cancer Treatment With Practice-Changing Data At ESMO 2019 – OBR

Please wait while we retrieve your external webpage

  • AstraZeneca PLC
  • Events
  • News Articles
  • News and Other Websites
  • Astellas Pharma Inc
  • Events
  • Social Updates
  • Twitter
N
Pfizer Inc.
Becker's Hospital Review· 16 Sep 2019

Common breast cancer drugs linked to severe lung illness, FDA warns

Common breast cancer drugs linked to severe lung illness, FDA warns Several commonly prescribed breast cancer drugs could lead to severe and even fatal lung issues, the FDA warned Sept. 13. The drugs included in the warning are Pfizer's Ibrance, Novartis' Kisqali, and Eli Lilly's Verzenio.

  • Pfizer Inc.
  • Novartis AG
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
  • AstraZeneca PLC
  • ReachMD - the Channel for Medical Professionals
  • Events
  • Social Updates
  • Twitter
N
Takeda Pharmaceutical Co Ltd
Chemdiv· 16 Sep 2019

Takeda recalls eye drug Natpara but warns patients not to abruptly stop treatment

Takeda recalls eye drug Natpara but warns patients not to abruptly stop treatment Takeda Pharmaceutical’s been looking for a buyer for Natpara to provide some debt relief, but it has just run into some complicating circumstances.

  • Takeda Pharmaceutical Co Ltd
  • Operational Challenges
  • News Articles
  • News and Other Websites
N
GlaxoSmithKline PLC
MassDevice· 16 Sep 2019

Judge adds $10m in damages in Vectura-GSK patent spat

This article has been updated with a statement from Glaxo Smith Kline. A federal judge in Delaware has awarded British inhaler company Vectura an additional $10.5 million in compensatory damages from Glaxo Smith Kline (NYSE:GSK) in a patent dispute.

  • GlaxoSmithKline PLC
  • Smith & Company
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Sanofi
Pharmafield· 16 Sep 2019

Sanofi & Abbott in diabetes management partnership

Sanofi and Abbott have partnered to integrate glucose sensing and insulin delivery technologies to help to further simplify how people with diabetes manage their condition. The collaboration aims to provide a connected device experience for millions of people living with diabetes using insulin.

  • Sanofi
  • Partnerships and Alliances
  • News Articles
  • News and Other Websites
N
Johnson & Johnson
The Center for Biosimilars· 16 Sep 2019

In Antitrust Case Over Remicade, J&J Wins the Right to Arbitration

The United States Court of Appeals for the Third Circuit has sided with Johnson & Johnson (J&J) and its Janssen division, requiring a dispute between the Remicade maker and Rochester Drug Cooperative (RDC) to be sent to arbitration.RDC is a direct purchaser and wholesaler of Remicade, J&J’s brand-name infliximab.

  • Johnson & Johnson
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
Twitter· 16 Sep 2019

BioSig Lands Licensing Deal with Mayo Clinic via @MDDIonline $BSGM $ABT $JNJ $MDT #MedTech #Healthcare #Electrophysiology #AFib https://t.co/HQL2zDxRp4

BioSig Lands Licensing Deal with Mayo Clinic
BioSig Technologies and Mayo Clinic have joined forces once again, this time to develop a new product pipeline to support some of the more advanced features of BioSig's Pure EP ...
  • Johnson & Johnson
  • MedTech
  • BioSig Technologies, Inc.
  • Mayo Clinic
  • ABT Corp
  • Procurement and Sales
  • Social Updates
  • Twitter
N
AstraZeneca PLC
FirstWord Pharma· 16 Sep 2019

AstraZeneca's SGLT2 inhibitor Farxiga granted fast track status by FDA for heart failure

AstraZeneca on Monday announced that the FDA awarded fast track designation to the oral once-daily SGLT2 inhibitor Farxiga (dapagliflozin) for lowering the risk of cardiovascular death or the worsening of heart failure in adults with heart failure with reduced ejection fraction or preserved ejection fraction.

  • AstraZeneca PLC
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Boehringer Ingelheim GmbH
Westfair Communications· 16 Sep 2019

Boehringer Ingelheim, Sanofi targeted in class-action suit over Zantac

A class-action lawsuit accusing Boehringer Ingelheim and Sanofi of intentionally concealing risks in the popular heartburn medication Zantac has been filed in the U.S. District Court for the Northern District of California. The suit maintains that Zantac has been found to contain a carcinogenic chemical at 26,000 times the limit approved by the U.S.

  • Boehringer Ingelheim GmbH
  • Sanofi
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
1 2 3 4 5